Job Title: Director
Company: Strategic Technology Bio Consulting
Mark Wilson is a consultant in the field of technology commercialisation, with twenty-five years’ experience of developing, commercialising and licensing novel technologies in the pharmaceutical industry.
Over the last five years, he has acted as a strategic adviser or interim business development director for a number of European biotech firms, has worked as the senior industry consultant for the UK Government’s Better Health Programme, supporting bilateral government-level health system development activities in Brazil, Mexico, South Africa and SE Asia, and has provided commercialisation advice to several major European public bodies and programmes (such as European Institute of Technology – Health and the EU’s accelerator programme, Invest Horizon). He has acted as an expert on corporate venturing practices for the IP Directorate of the European Commission, has provided strategic advice or support to technology incubators in Belgium, Portugal and Italy, and routinely coaches and mentors a number of early-stage biotech and med tech companies from across Europe.
Previously, he was a Director in GSK’s Platform Technology and Science division, seconded on a long-term basis into SR One (GSK’s wholly-owned corporate venture capital group). He was responsible for developing technology-based spin-outs and for out-licensing activity, and co-led this CEO-sponsored initiative. Mark worked for GSK in various licensing and alliance management roles for nearly twenty years and has been involved in over a hundred commercial transactions and alliances. He holds a Master’s degree and a doctorate in chemical engineering from the University of Leeds, in addition to an MBA from Columbia University and London Business School.